Home : News : News
JBSA News
Results:
Tag: NAMRU

NAMRU San Antonio conducts usability testing of portable ozone sterilizer
May 1, 2026
JOINT BASE SAN ANTONIO – FORT SAM HOUSTON – (April 3, 2026) – U.S. Army Staff Sgt. Jason Stokes, of Fort Cambell, Ky., an instructor with the Animal Health Branch, Division of Veterinary Science, U.S. Army Medical Department Center and School, participated in a usability test of the Rugged Ozone Sterilization System Model M1 (ROSS M1). During the month of April, NAMRU San Antonio research engineers visited with dental and veterinary science instructors to test the usability of the ROSS M1. The ROSS M1 is a portable device with the capability of sterilizing medical instruments on the battlefield or in austere environments which will help in the treatment and recovery of wounded warfighters. Navy Medicine Research & Development (NMR&D) employs highly qualified medical researchers and works alongside a wide range of research and development partners to keep abreast of best practices and advances in medical knowledge on behalf of Navy Medicine to increase warfighter lethality. NAMRU San Antonio, part of NMR&D, conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer, NAMRU San Antonio/Released)
DARPA’s FSHARP program manager visits NAMRU San Antonio, tours research laboratories
December 12, 2025
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Research scientist Phylisia Dimas, assigned to Naval Medical Research Unit (NAMRU) San Antonio, speaks with Dr. Jeremy Pamplin, program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), on the Nikon Eclipse Ti2 confocal microscope utilized for the assessment of DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program’s novel synthetic blood product at the Battlefield Health & Trauma Research Institute. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The confocal microscope can capture images of fixed and live tissue using magnifications from 4X to 60X at four different fluorescent filters. Other features include a controlled environmental chamber to perform live cell imaging, automation and software full of endless imaging and analysis tools. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)